Search - tctmd.com

Displaying 541 - 560 of 849

Sort: Relevancy | Date

News Daily News

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Jason Kahn

January 02, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

La Reestructuración de las Directrices STEMI pretende ser Acordes a la Práctica Clínica

December 19, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

December 05, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Longer Hospital Stay Linked with Less Evidence-Based Care in NSTEMI

Yael L. Maxwell

December 05, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Una Estancia Hospitalaria Más Larga se asocia a una Atención Menos Empríca tras un cuadro de NSTEMI

Yael L. Maxwell

December 05, 2012

News Daily News

Un Estudio de Registro Define el Papel Correcto de un Dispositivo para Embolizar Aneurismas Intracraneales

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Daily News

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

L.A. McKeown

November 28, 2012

News Daily News

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

November 13, 2012

News Conference News AHA 2012

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

November 05, 2012

Advertisement

Las Noticias Más Leídas del “Top 10” de TCTMD en 2012

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

Streamlined STEMI Guidelines Aim to Be Clinician-Friendly

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

La Reestructuración de las Directrices STEMI pretende ser Acordes a la Práctica Clínica

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Longer Hospital Stay Linked with Less Evidence-Based Care in NSTEMI

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Una Estancia Hospitalaria Más Larga se asocia a una Atención Menos Empríca tras un cuadro de NSTEMI

Un Estudio de Registro Define el Papel Correcto de un Dispositivo para Embolizar Aneurismas Intracraneales

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Bivalirudina muestra ventaja con respecto a los GPI — pero no la heparina sola — en pacientes con STEMI

Risk Peaks Early After Clopidogrel Cessation in SVG PCI Patients

No Mortality Benefit with Prolonged Dual Antiplatelet Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content